Our Vision

The Westmead Millennium Institute will continue to grow as a world leader in medical research with the power to improve the health of all mankind.

Our "Bench to Bedside" philosophy will ensure that our research outcomes are rapidly translated into better prevention strategies, treatments and healthcare for all.

News

The WMI Annual Report for 2008 is now available.

Click here for more information.

Gene variant provides clue to treating hepatitis C
Westmead Millennium Institute scientists led international team of medical researchers to identify a variant in the interferon gene IL28B, linking it with the treatment of chronic hepatitis C virus. Study results now online at Nature Genetics.

Click here for more information.

Eyes provide clues to a common cause of stroke

In a groundbreaking study researchers have concluded that evidence of the cause of "lacunar stroke" can be found by looking at the back of a patient's eyes.

Click here for more information.

WMI Researchers receive top cancer awards

Click here for more information on awards to the following WMI researchers: Dr Rosemary Balleine from Translational Oncology; Dr Liang Qiao and Dr Sarah Walker from the Storr Liver Unit, and all staff from the Sydney Melanoma Unit.

Breast Cancer Tissue Bank (BCTB) awarded Cancer Institute NSW Infrastructure Grant

Christine Clarke The BCTB has been awarded a Cancer Institute NSW Infrastructure Grant to assist with the collection, entry and auditing of clinical, pathology and specimen data, as well as data management solutions.

Click here for more information.

Links

Am I Depressed?
Sleep Awareness Week
(4 – 10 October)
World Sight Day - (8 October)
World Mental Health Day

The Westmead Millennium Institute is one of the largest medical research institutes in Australia with over 420 staff conducting research into a wide range of important human disorders affecting both adults and children.

Our research spans:

infectious and immune diseases
cancer and leukaemia
liver and metabolic diseases
eye and brain-related disorders
heart and respiratory disorders.

Closely affiliated with both Westmead Hospital and the University of Sydney, our research extends from the laboratory to the patient, using the basic tools of molecular and cell biology, genetic epidemiology, imaging technology and clinical research.

This ‘Bench to Bedside’ approach enables greater translation of research from biomedical discovery to the development of new prevention strategies, diagnostics and more effective treatments.

Research in focus - October 2009

Clinical A/Professor John Wheatley John Wheatley is a Clinical Associate Professor of Medicine in the Faculty of Medicine, University of Sydney, and Director of the Ludwig Engel Centre for Respiratory Research in the Westmead Millennium Institute.

In 1993, he was appointed as a Clinical Senior Lecturer and Staff Specialist in Respiratory Medicine at Westmead Hospital, and in 1995 was appointed as Director of the Department of Respiratory and Sleep Medicine and Director of the Sleep Laboratory at Westmead Hospital. He is also Director of the Department of Respiratory and Sleep Medicine at Westmead Hospital, and a Consultant Respiratory and Sleep Medicine Physician at Westmead Hospital.

His recent research work has demonstrated that snoring is a significant risk factor for carotid atherosclerosis, which carries implications for the management of snoring in relation to the prevention of stroke.

Dr Anthony Harris is the Deputy Director for Clinical Research & Head of the Clinical Disorders Unit at the Brain Dynamics Centre (BDC). He is the consultant psychiatrist for the Prevention Early Intervention and Recovery Service (PEIRS) in Western Sydney. He has successfully integrated this program with his schizophrenia research allied with BDC.

He is presently on the Management Committee of the Schizophrenia Fellowship of New South Wales and a member of the Board of the Research Trust Fund of the Fellowship. Dr Harris was the representative of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) on the Research Committee for the "Evidence based best practice guidelines for Schizophrenia" a project initiated by the NSW Department of Health and is the chairperson of the NSW Early Psychosis Research and Evaluation Working Group. He is involved in a number of panels of the Neuroscience Institute for Schizophrenia and Allied Disorders (NISAD).

| The University of Sydney

| Breast Cancer Tissue Bank

| Core Technology Platforms

| PhD Opportunities |

Search this site